Together, our findings for the first time identified DDAH-1 as a key player in the regulation of angiogenesis in human HCC, and by understanding this mechanism, future therapeutic strategies targeting VEGF can be improved. The gene discussed is DDAH1; the disease is hepatocellular carcinoma.